Skip to content

Measuring the effects of 3D Immersion Technology (3Scape) on mental health outpatients

Measuring the effects of 3D Immersion Technology (3Scape) on mental health outpatients of the START program at Glenrose Rehabilitation Hospital: a feasibility study

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN93685907
Enrollment
24
Registered
2020-10-07
Start date
2020-12-12
Completion date
Unknown
Last updated
2021-10-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Older adults’ depressive and anxiety symptoms, mood, overall quality of life, and engagement Mental and Behavioural Disorders

Interventions

The random sequence generation will be prepared in advance by a research team member in an Excel file spreadsheet (RAND function) using permuted block randomization with a block size of 4 and a ratio
other than that, they will receive the same standard care. The five 3D video screenings sessions will be delivered as one session per week for 6 weeks. Each session will take approximately 1 hour, con

Sponsors

Glenrose Rehabilitation Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Older adults aged 65 years and older 2. Cognitively intact or minimal cognitive impairment, i.e. Montreal Cognitive Assessment (MOCA) =22 3. Clients of the START Psychiatry Day Hospital program at GRH

Exclusion criteria

Exclusion criteria: 1. Unable to provide informed consent 2. Unable to communicate in the English language 3. Acute delirium 4. Significant sensory impairment (that would prevent adequate viewing of the 3D videos) 5. A mental health diagnosis with behavioral disturbances such as potential for aggression or severe agitation 6. Aphasia or other diagnosis that would prevent the subject from completing surveys

Design outcomes

Primary

MeasureTime frame
1. Depressive and anxiety symptoms assessed using the GAD7 (Generalized Anxiety Disorder – 7 item scale patient self-report tool) and HoNOS symptoms scale (Health of the Nations scale, a clinician rating tool) at baseline (week 0), posttest (week 6), end of the program (week 20) 2. Mood measured using PANAS (The Positive and Negative Affect Schedule, 20-item self-report questionnaire) measured after each video session, weeks 1, 2, 3, 4 and 5 3. Overall quality of life measured using OPQoL-Brief (Older People’s Quality of Life Scale – 13 items, self-reported tool) at baseline (week 0), posttest (week 6), end of the program (week 20)

Secondary

MeasureTime frame
Engagement while watching the 3Scape videos measured using an engagement scale developed by the team members in a previous study. This is an eight-point Likert scale that has been shown to be understood by older adults even those with mild cognitive impairments. Measured after each video session, weeks 1, 2, 3, 4 and 5

Countries

Canada

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 15, 2026